Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Co-Diagnostics Inc (NASDAQ: CODX) closed at $0.47 down -5.17% from its previous closing price of $0.49. In other words, the price has decreased by -$5.17 from its previous closing price. On the day, 8.28 million shares were traded. CODX stock price reached its highest trading level at $0.492 during the session, while it also had its lowest trading level at $0.427.
Ratios:
For a deeper understanding of Co-Diagnostics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.83 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 22540358 and an Enterprise Value of 6377638. For the stock, the TTM Price-to-Sale (P/S) ratio is 49.40 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 6.354 whereas that against EBITDA is -0.17.
Stock Price History:
The Beta on a monthly basis for CODX is 1.02, which has changed by -0.61322314 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $1.55, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 20.32%, while the 200-Day Moving Average is calculated to be 16.67%.
Shares Statistics:
For the past three months, CODX has traded an average of 24.74M shares per day and 120705860 over the past ten days. A total of 48.14M shares are outstanding, with a floating share count of 43.08M. Insiders hold about 10.53% of the company’s shares, while institutions hold 10.77% stake in the company. Shares short for CODX as of 1760486400 were 111948 with a Short Ratio of 0.00, compared to 1757894400 on 795088. Therefore, it implies a Short% of Shares Outstanding of 111948 and a Short% of Float of 0.25.
Earnings Estimates
. The current market rating for Co-Diagnostics Inc (CODX) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.68 and -$0.68 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.28, with 2.0 analysts recommending between -$0.17 and -$0.39.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $300k this quarter.It ranges from a high estimate of $300k to a low estimate of $300k. As of. The current estimate, Co-Diagnostics Inc’s year-ago sales were $641.14kFor the next quarter, 1 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $813k, while the lowest revenue estimate was $813k, resulting in an average revenue estimate of $813k. In the same quarter a year ago, actual revenue was $3.92MBased on 1 analysts’ estimates, the company’s revenue will be $1.35M in the next fiscal year. The high estimate is $1.35M and the low estimate is $1.35M.
